Cannabis Awareness

Understanding Cannabis in a Higher-THC World

Cannabis today is different from what it was 10 to 15 years ago.

Average THC levels in flower have increased significantly, and higher-potency products, including vape cartridges, edibles, and concentrates, are now widely available. These forms can deliver substantially higher levels of THC per use than traditional smoking.

This doesn’t make cannabis inherently harmful. But it does mean that dose, frequency, and method of use can lead to much higher THC exposure than in the past.

Over the past decade, research and clinical awareness have expanded around a set of cannabis-related patterns, such as:

  • Cannabinoid Hyperemesis Syndrome (CHS)
  • Cannabis-related anxiety and panic
  • Psychosis in more susceptible individuals

Some of this increased recognition is due to greater access, more people using cannabis, and improved clinical awareness. But research also points to another factor: higher THC exposure, especially when use is frequent or involves more concentrated products.

It’s also worth noting that sensitivity varies from person to person. Some individuals are more vulnerable to these effects, especially those with a personal or family history of certain mental health conditions, or other forms of individual sensitivity, which makes awareness and self-observation even more important.

In other words, the same pattern of use can produce very different outcomes depending on the individual.

This page outlines a few of the more common ways these patterns show up, including physical responses, mental and cognitive effects, behavioral shifts, and differences related to product and method of use.

Physical Responses (Including CHS)

Cannabis affects the gastrointestinal system as well as the brain.

Some users report physical changes such as:

  • Morning nausea or stomach discomfort
  • Changes in appetite or digestion
  • Increasing reliance on cannabis to relieve these symptoms

In less common cases, sustained high THC exposure, particularly with frequent use, has been associated with Cannabinoid Hyperemesis Syndrome (CHS), a condition involving recurrent nausea and vomiting.

CHS is most often reported in individuals using:

  • High-THC products, including concentrates, high-potency vape products, and high-dose edibles
  • On a daily or near-daily basis
  • Over extended periods of time, often over multiple years

Symptoms typically improve with cessation.

Cognitive and Mental Health Effects

Cannabis can influence mood, perception, and cognition, especially at higher THC levels.

Reported effects include:

  • Anxiety or paranoia
  • Reduced mental clarity or persistent brain fog
  • Changes in motivation or mood

Many of these effects, such as anxiety, motivation, and mood changes, are influenced by a combination of factors, including individual psychology, environment, and patterns of use.

However, there is a substantial body of research showing an association between frequent use of high-THC cannabis and an increased risk of psychotic symptoms, particularly in individuals with underlying vulnerability (for example, a personal or family history of psychotic disorders).

Risk appears to increase with:

  • Higher potency
  • Greater frequency
  • Earlier age of onset

Pattern Shift: From Intentional to Automatic Use

In addition to physical and mental effects, changes can also show up in patterns of use.

Some individuals notice:

  • Use becoming routine or automatic
  • Difficulty reducing or pausing
  • Use driven more by habit than intention

This is sometimes seen as a shift in the relationship to cannabis, from intentional to automatic use. It may also be influenced by factors such as product potency, frequency of use, and individual susceptibility.

Product Awareness and Sourcing

Another variable that often gets overlooked is the product itself.

Cannabis is not a uniform substance. Even products labeled similarly can vary meaningfully between batches and sources. Different products can vary significantly in:

  • THC concentration
  • Cannabinoid profile (for example, presence of CBD)
  • Terpene composition
  • Method of delivery (smoked flower vs vapes, edibles, concentrates)

These differences can affect how much THC is absorbed, how quickly it takes effect, and how the experience unfolds.

Having access to clearly labeled, tested products makes it easier to:

  • Understand THC levels
  • Adjust dose more precisely
  • Avoid unintentionally high exposure

In contrast, when sourcing is inconsistent or unknown, it becomes much more difficult to gauge:

  • Potency
  • Composition
  • Expected effects

This shows there are certainly areas to be mindful of for any individual who engages with cannabis. The more you understand what you’re using, the easier it is to align your use with your intended outcome.

Method of Use

The way cannabis is consumed also affects exposure and overall impact.

Different methods, including smoking, vaporizing, and edibles, vary in how quickly THC is absorbed, how long effects last, and how easy it is to regulate dose.

Smoking (flower):

  • Produces rapid onset, making it easier to gauge effects in real time
  • However, combustion generates additional byproducts that are inhaled along with cannabinoids

Dry herb vaporizing (e.g., devices like Pax):

  • Heats cannabis without full combustion
  • Often considered an alternative to smoking that avoids combustion and may reduce exposure to some combustion-related byproducts
  • Still delivers THC efficiently, so overall exposure depends on dose and frequency
  • Long-term health effects are still being studied

Vaping (cartridges or concentrates):

  • Can reduce some combustion-related byproducts
  • Often delivers higher THC concentrations
  • The ease and convenience of use may lead to more frequent dosing, which can increase overall exposure
  • Long-term health effects are still being studied

Edibles:

  • Slower onset (often 30 to 120 minutes)
  • Longer-lasting effects
  • Can make dose regulation more difficult, increasing the risk of unintended overconsumption
  • Product quality and ingredient composition can vary

Each method has tradeoffs. None are entirely risk-free.

What matters most is understanding how each one affects:

  • Total THC exposure
  • Frequency of use
  • Ability to regulate dose

Many people use cannabis for years without significant issues.

But with higher-potency products and more concentrated forms now widely available, these variables carry more weight than they did in the past.

Summary

Current evidence suggests that cannabis-related adverse effects are most strongly associated with:

  • Higher THC exposure (for example, regular use of flower in the approximately 15 to 20 percent or higher THC range, or concentrated forms such as vapes, dabs, or high-dose edibles)
  • Frequent or daily use
  • Use over extended periods of time
  • Use during adolescence and early adulthood (when the brain is still developing, roughly into the mid-20s)
  • Individual susceptibility (including personal or family history of certain mental health conditions)

These factors interact, meaning outcomes are shaped not just by the substance itself, but by how it is used, how often, the form and quality of the product, and individual differences.

This information is provided to support a more informed and intentional approach to cannabis use, particularly in the context of modern, higher-potency products.

Sources

  • Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment. Journal of Medical Toxicology. 2017.
  • American Gastroenterological Association clinical updates on CHS.
  • Di Forti M et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe. Lancet Psychiatry. 2019.
  • National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids. 2017.
  • Volkow ND et al. Effects of Cannabis Use on Human Behavior. JAMA Psychiatry. 2016.
  • ElSohly MA et al. University of Mississippi Potency Monitoring Program reports.